Page 0015

GLOBAL CANCER INITIATIVES

15 CANCER CONTROL 2021

1. WHO Report on cancer: setting priorities, investing wisely and providing care for all.

World Health Organization. 2020.

2. The Global Antibiotic Research & Development Partnership (GARDP). Addressing

antimicrobial resistance for better care in cancer patients. Accessed October 01, 2021.

Addressing antimicrobial resistance for better care in cancer patients - by Yehoda M.

Martei and Shalini J. Zürn - REVIVE (gardp.org)

3. Norwegian Cancer Society. What are the consequences of antibiotic resistance for

cancer patients? Accessed July 15, 2021. https://kreftforeningen.no/en/antimicrobial-resistance-amr/what-are-the-consequences-of-antibiotic-resistance-for-cancer-patients

4. The Union for International Cancer Control. Antimicrobial resistance and its impact on

cancer care. Accessed July 30, 2021. https://www.uicc.org/what-we-do/thematic-areas-work/antimicrobial-resistance-and-its-impact-cancer-care

5. The Global Antibiotic Research & Development Partnership (GARDP). Addressing

antimicrobial resistance for better care in cancer patients. Accessed October 01, 2021.

Addressing antimicrobial resistance for better care in cancer patients - by Yehoda M.

Martei and Shalini J. Zürn - REVIVE (gardp.org)

6. Rolston KV. Infections in Cancer Patients with Solid Tumors: A Review. Infect Dis Ther.

2017;6(1):69-83. doi:10.1007/s40121-017-0146-1

7. idem

8. Williams MD et al. Hospitalized cancer patients with severe sepsis: analysis of incidence,

mortality, and associated costs of care. Crit Care. 2004;8(5):R291-298.

8. ReAct. The global threat of antibiotic resistance. Accessed July 30, 2021. https://www.

reactgroup.org/antibiotic-resistance/the-threat/

9. Kumar A, Mohapatra S, Bakhshi S, Mahapatra M, Sreenivas V, Das BK (2018) Rectal

Carriage of Carbapenem-Resistant Enterobacteriaceae: A Menace to Highly Vulnerable

Patients. Journal of Global Infectious Diseases. 10(4):218-221 https://www.ncbi.nlm.nih.

gov/pmc/articles/PMC6276316/

10. Fentie A, Wondimeneh Y, Balcha A, Amsalu A, Adankie BT (2018) Bacterial profile,

antibiotic resistance pattern and associated factors among cancer patients at University

of Gondar Hospital, Northwest Ethiopia. Infection and Drug Resistance 11:2169-2178

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233944/

11. London Global Cancer Week. Accessed July 30, 2021. https://www.lgcw.org.uk/

12. Wellcome Trust. How drug resistance infections are undermining modern medicine and

why more research is needed now. Published July 14, 2021. Accessed August 17, 2021.

https://wellcome.org/reports/how-drug-resistant-infections-are-undermining-modern-medicine-and-why-more-research-needed

13.The Global Antibiotic Research & Development Partnership (GARDP). Addressing

antimicrobial resistance for better care in cancer patients. Accessed October 01, 2021.

Addressing antimicrobial resistance for better care in cancer patients - by Yehoda M.

Martei and Shalini J. Zürn - REVIVE (gardp.org)

14. ReAct. Antibiotic resistance. Take action. Accessed September 4, 2021. https://www.

reactgroup.org/antibiotic-resistance/take-action/

15. The Fleming Fund. Accessed September 4. https://www.flemingfund.org/

16. The Fleming Fund. Quarter 3,2020. Programme update. Accessed September 4,

2021. https://www.flemingfund.org/wp-content/uploads/9a4c1cc5bd2913e0af34c083bf621895.pdf

17. Longitude Prize report. Effectiveness of cancer treatments threatened by rising

antibiotic resistance. Published February, 2020. Accessed September 1, 2021. https://

longitudeprize.org/wp-content/uploads/sites/74/2021/04/Longitude-Prize-Report_EFFECTIVENESS-OF-CANCER-TREATMENTS-THREATENED-BY-RISING-ANTIBIOTIC-RESISTANCE_FINAL-2-1.pdf

18. The Union for International Cancer Control. The role of UICC and its members on

Antimicrobial resistance. Accessed July 30, 2021. https://www.uicc.org/what-we-do/

thematic-areas-work/antimicrobial-resistance/role-uicc-and-its-members-antimicrobial

19. Kållberg C, Årdal C, Salvesen Blix H, Klein E, M Martinez E, Lindbæk M, Outterson K,

Røttingen JA, Laxminarayan R. Introduction and geographic availability of new antibiotics approved

between 1999 and 2014. 2018

References

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066